Evidence map›Paper›PMID 27317098›Full record

ArticleBMC genetics2016

Repetitive element hypermethylation in multiple sclerosis patients.

K Y Neven, M Piola, L Angelici, F Cortini, C Fenoglio, D Galimberti, A C Pesatori, E Scarpini, V Bollati

Open access · diamondAbstract read
In one paragraph

Article in BMC genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Identifying the culprits in neurological autoimmune diseases.Journal of translational autoimmunity · 2019
    Review
  5. Article
  6. Review
  7. Article
  8. Transposable elements and the multidimensional genome.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2018
    Review
  9. Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

K Y NevenDepartment of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Lab, Università degli Studi di Milano, Milan, Italy.
M PiolaNeurology Unit, Saronno ASST Valle Olona Hospital, Saronno, Italy.
L AngeliciDepartment of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Lab, Università degli Studi di Milano, Milan, Italy.
F CortiniDepartment of Preventive Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Epidemiology Unit, Milan, Italy.
C FenoglioDepartment of Pathophysiology and Transplantation, Dino Ferrari Centre, Università degli Studi di Milano and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
D GalimbertiDepartment of Pathophysiology and Transplantation, Dino Ferrari Centre, Università degli Studi di Milano and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
A C PesatoriDepartment of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Lab, Università degli Studi di Milano, Milan, Italy.
E ScarpiniDepartment of Pathophysiology and Transplantation, Dino Ferrari Centre, Università degli Studi di Milano and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
V BollatiDepartment of Clinical Sciences and Community Health, EPIGET - Epidemiology, Epigenetics and Toxicology Lab, Università degli Studi di Milano, Milan, Italy. valentina.bollati@unimi.it.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milan · ITAccademia Italiana Medicina Osteopatica · ITHasselt University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is a complex disorder of the central nervous system whose cause is currently unknown. Evidence is increasing that DNA methylation alterations could be involved in inflammatory and neurodegenerative diseases and could contribute to MS pathogenesis. Repetitive elements Alu, LINE-1 and SAT-α, are widely known as estimators of global DNA methylation. We investigated Alu, LINE-1 and SAT-α methylation levels to evaluate their difference in a case-control setup and their role as a marker of disability.

resultsWe obtained blood samples from 51 MS patients and 137 healthy volunteers matched by gender, age and smoking. Methylation was assessed using bisulfite-PCR-pyrosequencing. For all participants, medical history, physical and neurological examinations and screening laboratory tests were collected. All repetitive elements were hypermethylated in MS patients compared to healthy controls. A lower Expanded Disability Status Scale (EDSS) score was associated with a lower levels of LINE-1 methylation for 'EDSS = 1.0' and '1.5 ≤ EDSS ≤ 2.5' compared to an EDSS higher than 3, while Alu was associated with a higher level of methylation in these groups: 'EDSS = 1.0' and '1.5 ≤ EDSS ≤ 2.5'.

conclusionsMS patients exhibit an hypermethylation in repetitive elements compared to healthy controls. Alu and LINE-1 were associated with degree of EDSS score. Forthcoming studies focusing on epigenetics and the multifactorial pathogenetic mechanism of MS could elucidate these links further.

Indexed as

DNA MethylationRepetitive Sequences, Nucleic AcidAdultAlu ElementsFemaleHumansLong Interspersed Nucleotide ElementsMaleMultiple SclerosisDNA methylationEpigeneticsExpanded disability status scaleHypermethylationMultiple sclerosisRepetitive elements

Identifiers

PMID27317098
PMCPMC4912727
OpenAlexW2421217190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.